Advertisement

Topics

Aroa Biosurgery Ltd Company Profile

07:43 EDT 19th September 2018 | BioPortfolio

Aroa Biosurgery (Aroa) is a privately held soft tissue repair and reconstruction company.


News Articles [9 Associated News Articles listed on BioPortfolio]

EU approves surgical implants from Aroa Biosurgery

European regulators gave Aroa Biosurgery CE mark approval for its OviTex Reinforced BioScaffold devices, which consist of int -More- 

Aroa Biosurgery and Hydrofera Team up in US

New Zealand biomedical company Aroa Biosurgery and United States medical products company Hydrofera are launching Appulse in North America. The two companies have ...

Biosurgery Market - Global Forecast to 2023

DUBLIN, July 26, 2018 /PRNewswire/ -- The "Biosurgery Market by Product (Fibrin/Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitut...

Biosurgery Market by Product Fibrin Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes Application Orthopedic, Gynecology, Cardiovascular, Reconstructive Forecast to 2023 [Report Up

The biosurgery market projected to grow at a CAGR of 6.5%.The biosurgery market is projected to reach USD 15.58 billion by 2023 from estimated USD 11.36 billion in 2018 at a CAGR of 6.5%. Factors such...

TRX BioSurgery Receives Supplier Horizon Award from Premier Inc.

TRX BioSurgery, part of the Tissue Regenix Group, today announces that it is a winner of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement comp...

Tissue Regenix says sales in CellRight and BioSurgery divisions have had a strong start to the year

"We have completed a transformative acquisition, delivered 46% growth in DermaPure sales and expanded the clinical applications of our products to access new healthcare professionals," said company ch...

Tissue Regenix says sales in CellRight and BioSurgery divisions started year strongly

"We have completed a transformative acquisition, delivered 46% growth in DermaPure sales and expanded the clinical applications of our products to access new healthcare professionals," said company ch...

Hardman & Co Research: Tissue Regenix (TRX): 1H’18 preview: organic plus inorganic growth

Hardman & Co Research 02-Aug-2018 / 10:10 GMT/BST Hardman & Co: 2018: 1H’18 preview: organic plus inorganic growth TRX has a broad portfolio of regenerative medicine products for the b...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Carticel [Genzyme Corporation]

These highlights do not include all the information needed to use Carticel safely and effectively. See full prescribing information for Carticel. Carticel® (autologous cultured chondrocytes) For Auto...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence.

The initial virulence and invasiveness of a bacterial strain may play an important role in leading to a maximally efficacious attenuated live vaccine. Here we show that χ9909, derived from Salmonella...

Oral Delivery of a DNA Vaccine Expressing the PrM and E Genes: A Promising Vaccine Strategy against Flavivirus in Ducks.

A flavivirus, named duck tembusu virus (DTMUV), emerged in China in 2010. This virus has caused great economic losses in the poultry industry in China and may pose a threat to public health. As a safe...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds. Captique® is an FDA-approve...

A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to evaluate the safety and effectiveness of injection with DGE Injectable Gel (manufactured by Genzyme Biosurgery) as compared to injection with a Foo...

Companies [9 Associated Companies listed on BioPortfolio]

Aroa Biosurgery Ltd

Aroa Biosurgery (Aroa) is a privately held soft tissue repair and reconstruction company.

BioMonde, LLC

Since 1994 BioMonde have manufactured and supplied Larval Therapy in Europe and the UK. BioMonde are the sole producers of ‘BioBag,’ which provides clinicians and patien...

Orthovita, Inc.

Orthovita, Inc. is a specialty spine and orthopedic company with a portfolio of orthobiologic and biosurgery products. Our products are based on novel and unique proprietary bioma...

Organogenesis

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a leading regenerative medicine company focused in the areas of bioactive wound healing, oral regeneration and biosurgery. The co...

Organogenesis, Inc.

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a leading regenerative medicine company focused in the areas of bioactive wound healing, oral regeneration and biosurgery. The co...

More Information about "Aroa Biosurgery Ltd" on BioPortfolio

We have published hundreds of Aroa Biosurgery Ltd news stories on BioPortfolio along with dozens of Aroa Biosurgery Ltd Clinical Trials and PubMed Articles about Aroa Biosurgery Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aroa Biosurgery Ltd Companies in our database. You can also find out about relevant Aroa Biosurgery Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record